About Us
Who We Are?
We are LightAI – a team of visionaries, innovators, and multidisciplinary problem-solvers driven by a shared calling to harness artificial intelligence for the greater good. Guided by compassion and an unwavering commitment to equity, we develop solutions that empower individuals, strengthen communities, and create a brighter future for all—regardless of background or economic circumstances.
Our Journey
Our journey began with a mission to transform diagnostics, addressing global challenges like antimicrobial resistance and healthcare access.
2015: Founding LightAI
LightAI was founded to combat the growing threat of antimicrobial resistance (AMR) caused by the misuse and overprescription of antibiotics. We envisioned solutions that ensure antibiotics were prescribed only when necessary.
2016-2019: Laying the Foundation
LightAI collaborated with leading institutions to create a robust database differentiating viral and bacterial infections. In parallel, the first version of LightAI’s diagnostic device was developed along with validation of algorithms through early trials. Funding was secured to expand its scope.
2020-2021: Pivot to Smartphones
The COVID-19 pandemic presented an opportunity for LightAI to adapt its technology for use with smartphones, enabling fast, non-invasive diagnostics for COVID-19 and other illnesses. This development expanded the potential applications of its technology and demonstrated its versatility in addressing global health concerns.
2022: Cementing Our Footprint
Recognizing the global need for innovative diagnostics, LightAI collaborated with international organizations to validate its strep detection technology in real-world settings, achieving a 96.7% detection accuracy.
2023-2024: Global Readiness
Building on its success, LightAI formed partnerships to enhance its outreach and delivery, particularly in emerging markets such as Africa and India.
Our Vision
To be the global leader in advanced intelligence-enabled vision systems to support rapid accurate practitioner diagnosis.
Our Purpose
We empower health providers with technology—driven intelligence—assistive innovations to better prevent, diagnose, and manage infectious diseases—transforming care and improving lives.
Our Beliefs
Technology must deliver value
Every solution we create is designed to improve lives and serve the greater good.
Equity drives progress
Breaking down barriers ensures opportunity for all.
Purposeful collaboration amplifies impact
Together, we can achieve the extraordinary.
Compassion fuels purpose
Empathy is at the heart of meaningful change.
Change propels us forward
We evolve to meet the needs of a changing world.
Our Values
Integrity
We uphold the highest ethical standards, fostering trust and transparency in every decision and solution.
Equity
We champion fairness and inclusivity, breaking barriers to ensure access to opportunities for all.
We push boundaries with bold thinking, transforming challenges into impactful solutions.
Innovation
Empowerment
We equip individuals and communities with tools and knowledge to thrive and shape their futures.
We prioritize well-being, creating solutions rooted in empathy and service to the greater good.
Compassion
Impact
We are deliver meaningful results, creating solutions that drive real, lasting change and value.
Our People
We continue to expand our impact with a team of multidisciplinary experts – across healthcare, technology – steadfast in our belief that technology should serve humanity.
Officers
Peter Whitehead
CEO
George Reznik
CFO and Corporate Secretary
Thomas Scarnecchia
COO
Advisors
Anthony Schaller
David Talan
Yu Zhao
Raymond Ng
David Bell
Board
Steven Semmelmayer
Chair
Mark Attanasio
Hugh Cleland
Emmanuel Blin
